Acne through the ages: Case-based observations through childhood and adolescence

Clinical Pediatrics

Volumn 47, Issue 7, 2008, Pages 639-651

  Tom, Wynnis L ^b   Fallon Friedlander, Sheila ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b NONE

Author keywords

Acne therapy; Acne vulgaris; Adolescent; Infantile; Mid childhood or prepubertal; Neonatal

Indexed keywords

ADAPALENE; AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN; CORTICOSTEROID; DEXAMETHASONE; DOXYCYCLINE; DROSPIRENONE PLUS ESTRADIOL; ERYTHROMYCIN; ETHINYLESTRADIOL PLUS NORGESTIMATE; ISOTRETINOIN; KETOCONAZOLE; METFORMIN; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT; RETINOIC ACID; RETINOID; RETINOL; SALICYLIC ACID; SPIRONOLACTONE; SULFACETAMIDE; TAZAROTENE; TETRACYCLINE; TRIAMCINOLONE ACETONIDE;

ACNE VULGARIS; ADD ON THERAPY; ADOLESCENT; ADRENAL CORTEX; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; BRAIN PSEUDOTUMOR; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEADACHE; HEALTH PRACTITIONER; HORMONAL THERAPY; HUMAN; HYPERANDROGENISM; INFANT; MALE; MYALGIA; NEWBORN; SINGLE DRUG DOSE; SKIN DEFECT; SKIN EXAMINATION; TREATMENT DURATION; VACCINATION; XEROSIS;

ACNE VULGARIS; ADOLESCENT; CHILD; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERANDROGENISM; INFANT, NEWBORN; ISOTRETINOIN; MALE;

EID: 48449089287     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922808315444     Document Type: Article

References (79)

1. Dreno B., Poli F. Epidemiology of acne. Dermatology. 2003 ; 206: 7-10.
2. Collier CN, Harper JC, Cantrell WC, Wang W., Foster KW, Elewski BE The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008 ; 58: 56-59.
3. Krakowski AC, Eichenfield LF Pediatric acne: clinical presentations, evaluation, and management. J Drugs Dermatol. 2007 ; 6: 584-588.
4. Essah PA, Wickham EP, III, Nunley JR, Nestler JE Dermatology of androgen-related disorders. Clin Dermatol. 2006 ; 24: 289-298.
5. Mann MW, Ellis SS, Mallory SB Infantile acne as the initial sign of an adrenocortical tumor. J Am Acad Dermatol. 2007 ; 56 (suppl): 15S - 18S.
6. Yan AC Current concepts in acne management. Adolesc Med Clin. 2006 ; 17: 613-637.
7. Kilkenny M., Merlin K., Plunkett A., Marks R. The prevalence of common skin conditions in Australian school students: 3. acne vulgaris. Br J Dermatol. 1998 ; 139: 840-845.
8. Tan JK Psychosocial impact of acne vulgaris: evaluating the evidence. Skin Therapy Lett. 2004 ; 9: 1-3, 9.
9. Baldwin HE The interaction between acne vulgaris and the psyche. Cutis. 2002 ; 70: 133-139.
10. Fried RG, Wechsler A. Psychological problems in the acne patient. Dermatol Ther. 2006 ; 19: 237-240.
11. Kellett SC, Gawkrodger DJ The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol. 1999 ; 140: 273-282.
12. Pearl A., Arroll B., Lello J., Birchall NM The impact of acne: a study of adolescents' attitudes, perception and knowledge. N Z Med J. 1998 ; 111: 269-271.
13. Smithard A., Glazebrook C., Williams HC Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study. Br J Dermatol. 2001 ; 145: 274-279.
14. Eichenfield LF, Fried RG, Taylor SC, Paller AS, Theos A. Acne and your pediatric patient: a roundtable discussion of treatment modalities and other factors. Cutis. 2005 ; 76 (suppl 5). 5-24.
15. Layton AM Optimal management of acne to prevent scarring and psychological sequelae. Am J Clin Dermatol. 2001 ; 2: 135-141.
16. Picardi A., Mazzotti E., Pasquini P. Prevalence and correlates of suicidal ideation among patients with skin disease. J Am Acad Dermatol. 2006 ; 54: 420-426.
17. Gupta MA, Gupta AK Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998 ; 139: 846-850.
18. Jansen T., Burgdorf WH, Plewig G. Pathogenesis and treatment of acne in childhood. Pediatr Dermatol. 1997 ; 14: 17-21.
19. Herane MI, Ando I. Acne in infancy and acne genetics. Dermatology. 2003 ; 206: 24-28.
20. Katsambas AD, Katoulis AC, Stavropoulos P. Acne neonatorum: a study of 22 cases. Int J Dermatol. 1999 ; 38: 128-130.
21. Shaw JC Acne: effect of hormones on pathogenesis and management. Am J Clin Dermatol. 2002 ; 3: 571-578.
22. Zouboulis CC Acne and sebaceous gland function. Clin Dermatol. 2004 ; 22: 360-366.
23. Niamba P., Weill FX, Sarlangue J., Labreze C., Couprie B., Taieh A. Is common neonatal cephalic pustulosis (neonatal acne) triggered by Malassezia sympodialis ? Arch Dermatol. 1998 ; 134: 995-998.
24. Bernier V., Weill FX, Hirigoyen V., et al. Skin colonization by Malassezia species in neonates: a prospective study and relationship with neonatal cephalic pustulosis. Arch Dermatol. 2002 ; 138: 215-218.
25. Bergman JN, Eichenfield LF Neonatal acne and cephalic pustulosis: is malassezia the whole story ? Arch Dermatol. 2002 ; 138: 255-257.
26. Cantatore-Francis JL, Glick SA Childhood acne: evaluation and management. Dermatol Ther. 2006 ; 19: 202-209.
27. Rapelanoro R., Mortureux P., Couprie B., Maleville J., Taieb A. Neonatal Malassezia furfur pustulosis. Arch Dermatol. 1996 ; 132: 190-193.
28. Barnes CJ, Eichenfield LF, Lee J., Cunningham BB A practical approach for the use of oral isotretinoin for infantile acne. Pediatr Dermatol. 2005 ; 22: 166-169.
29. Cunliffe WJ, Baron SE, Coulson IH A clinical and therapeutic study of 29 patients with infantile acne. Br J Dermatol. 2001 ; 145: 463-466.
30. Lucky AW A review of infantile and pediatric acne. Dermatology. 1998 ; 196: 95-97.
31. Lucky AW Acne therapy in infancy and childhood. Dermatol Ther. 1998 ; 6: 74-81.
32. Goulden V. Guidelines for the management of acne vulgaris in adolescents. Paediatr Drugs. 2003 ; 5: 301-313.
33. Levine RM, Rasmussen JE Intralesional corticosteroids in the treatment of nodulocystic acne. Arch Dermatol. 1983 ; 119: 480-481.
34. Accutane [package insert]. Nutley, NJ: Roche Laboratories ; 2005.
35. Torrelo A., Pastor MA, Zambrano A. Severe acne infantum successfully treated with isotretinoin. Pediatr Dermatol. 2005 ; 22: 357-359.
36. Katsambas A., Papakonstantinou A. Acne: systemic treatment. Clin Dermatol. 2004 ; 22: 412-418.
37. Chew EW, Bingham A., Burrows D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp Dermatol. 1990 ; 15: 376-377.
38. De Raeve L., De SJ, Smitz J. Prepubertal acne: a cutaneous marker of androgen excess? J Am Acad Dermatol. 1995 ; 32 (2, pt 1). 181-184.
39. Lucky AW, Biro FM, Huster GA, Leach AD, Morrison JA, Ratterman J. Acne vulgaris in premenarchal girls. An early sign of puberty associated with rising levels of dehydroepiandrosterone. Arch Dermatol. 1994 ; 130: 308-314.
40. Lucky AW, Biro FM, Huster GA, Morrison JA, Elder N. Acne vulgaris in early adolescent boys. Correlations with pubertal maturation and age. Arch Dermatol. 1991 ; 127: 210-216.
41. Krowchuk DP Managing adolescent acne: a guide for pediatricians. Pediatr Rev. 2005 ; 26: 250-261.
42. Jozwiak S., Schwartz RA, Janniger CK, Michalowicz R., Chmielik J. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int J Dermatol. 1998 ; 37: 911-917.
43. Baldwin HE Tricks for improving compliance with acne therapy. Dermatol Ther. 2006 ; 19: 224-236.
44. Bojar RA, Holland KT Acne and Propionibacterium acnes. Clin Dermatol. 2004 ; 22: 375-379.
45. Eady AE, Cove JH, Layton AM Is antibiotic resistance in cutaneous propionibacteria clinically relevant? Implications of resistance for acne patients and prescribers. Am J Clin Dermatol. 2003 ; 4: 813-831.
46. Eady EA, Gloor M., Leyden JJ Propionibacterium acnes resistance: a worldwide problem. Dermatology. 2003 ; 206: 54-56.
47. Leyden J., Levy S. The development of antibiotic resistance in Propionibacterium acnes. Cutis. 2001 ; 67 (suppl 2). 21-24.
48. Leyden JJ Antibiotic resistance in the topical treatment of acne vulgaris. Cutis. 2004 ; 73 (suppl 6). 6-10.
49. Swanson JK Antibiotic resistance of Propionibacterium acnes in acne vulgaris. Dermatol Nurs. 2003 ; 15: 359-362.
50. Tanghetti E. The impact and importance of resistance. Cutis. 2007 ; 80 (suppl 1). 5-9.
51. Ross JI, Snelling AM, Carnegie E., et al. Antibioticresistant acne: lessons from Europe. Br J Dermatol. 2003 ; 148: 467-478.
52. Eady EA, Bojar RA, Jones CE, Cove JH, Holland KT, Cunliffe WJ The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol. 1996 ; 134: 107-113.
53. Eady EA, Farmery MR, Ross JI, Cove JH, Cunliffe WJ Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and-resistant skin bacteria from acne patients. Br J Dermatol. 1994 ; 131: 331-336.
54. Leyden JJ, Del Rosso JQ, Webster GF Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis. 2007 ; 79 (suppl 6). 9-25.
55. Katsambas AD, Stefanaki C., Cunliffe WJ Guidelines for treating acne. Clin Dermatol. 2004 ; 22: 439-444.
56. Gollnick H., Cunliffe W., Berson D., et al. Management of acne: a report from a Global Alliance to improve outcomes in acne. J Am Acad Dermatol. 2003 ; 49 (suppl 1). 1S - 37S.
57. Webster GF The pathophysiology of acne. Cutis. 2005 ; 76 (suppl 2). 4-7.
58. Bergfeld WF The pathophysiology of acne vulgaris in children and adolescents, Part 1. Cutis. 2004 ; 74: 92-97.
59. Harper JC, Thiboutot DM Pathogenesis of acne: recent research advances. Adv Dermatol. 2003 ; 19: 1-10.
60. Tan JK, Vasey K., Fung KY Beliefs and perceptions of patients with acne. J Am Acad Dermatol. 2001 ; 44: 439-445.
61. Cordain L. Implications for the role of diet in acne. Semin Cutan Med Surg. 2005 ; 24: 84-91.
62. Zaenglein AL, Thiboutot DM Expert committee recommendations for acne management. Pediatrics. 2006 ; 118: 1188-99.
63. Adebamowo CA, Spiegelman D., Danby FW, Frazier AL, Willett WC, Holmes MD High school dietary dairy intake and teenage acne. J Am Acad Dermatol. 2005 ; 52: 207-214.
64. Smith RN, Mann NJ, Braue A., Makelainen H., Varigos GA The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol. 2007 ; 57: 247-256.
65. Smith RN, Mann NJ, Braue A., Makelainen H., Varigos GA A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr. 2007 ; 86: 107-115.
66. Strauss JS, Krowchuk DP, Leyden JJ, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007 ; 56: 651-663.
67. Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol. 2004 ; 22: 419-428.
68. Tan AW, Tan HH Acne vulgaris: a review of antibiotic therapy. Expert Opin Pharmacother. 2005 ; 6: 409-418.
69. Sturkenboom MC, Meier CR, Jick H., Stricker BH Minocycline and lupuslike syndrome in acne patients. Arch Intern Med. 1999 ; 159: 493-497.
70. Skidmore R., Kovach R., Walker C., et al. Effects of sub-antimicrobial- dose doxycycline in the treatment of moderate acne. Arch Dermatol. 2003 ; 139: 459-464.
71. Bershad SV The modern age of acne therapy: a review of current treatment options. Mt Sinai J Med. 2001 ; 68: 279-286.
72. Boni R., Nehrhoff B. Treatment of gram-negative folliculitis in patients with acne. Am J Clin Dermatol. 2003 ; 4: 273-276.
73. Deplewski D., Rosenfield RL Role of hormones in pilosebaceous unit development. Endocr Rev. 2000 ; 21: 363-392.
74. Berger R., Barba A., Fleischer A., et al. A double-blinded, randomized, vehicle-controlled, multicenter, parallel-group study to assess the safety and efficacy of tretinoin gel microsphere 0.04% in the treatment of acne vulgaris in adults. Cutis. 2007 ; 80: 152-157.
75. Marqueling AL, Zane LT Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2005 ; 24: 92-102.
76. Layton AM, Knaggs H., Taylor J., Cunliffe WJ Isotretinoin for acne vulgaris-10 years later: a safe and successful treatment. Br J Dermatol. 1993 ; 129: 292-296.
77. White GM, Chen W., Yao J., Wolde-Tsadik G. Recurrence rates after the first course of isotretinoin. Arch Dermatol. 1998 ; 134: 376-378.
78. Stainforth JM, Layton AM, Taylor JP, Cunliffe WJ Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course ? Br J Dermatol. 1993 ; 129: 297-301.
79. DiGiovanna JJ Isotretinoin effects on bone. J Am Acad Dermatol. 2001 ; 45: 176S - 182S.